 intermitt concurr regimen zidovudin dideoxycytidin murin immunodefici model murin retrovirus-induc immunodefici model efficaci intermitt regimen zidovudin azt dideoxycytidin ddc continu concurr therapi intermitt oral azt therapi effect mice viru continu oral azt therapi continu oral ddc therapi mg/kg/day surviv time averag week untreat mice weekli azt ddc therapi surviv time week effect therapi addit synergist concurr azt ddc therapi effect continu azt therapi model increas surviv time